Project Grant R01GM152642

Award Date 9/1/24
Completion Date 8/31/28
Dollars Obligated $384K
Federal Grant Program
93.859
Assistance Type
Project Grant
Place of Performance
Boulder, CO 80309, USA
Similar Awards
This $1.2 million National Science Foundation project grant, awarded under the Biological Sciences program (CFDA 47.074), will fund research at the University of North Carolina at Chapel Hill from March 2023 through February 2027 toward developing a revised model of the cell cycle that captures reversible and irreversible cell cycle arrest. The principal investigator will define the molecular mechanisms governing the transition between reversible quiescence and irreversible senescence, as well...
The National Institute of General Medical Sciences (NIGMS) awarded a $427,571 Project Grant under the Biomedical Research and Research Training program (CFDA 93.859) to The Regents of the University of Colorado, doing business as the University of Colorado-Denver. The award, which runs from January 15, 2025 to December 31, 2029, will support research to uncover the molecular determinants of cellular identity and the regulation of chromatin states across the cell cycle. Specifically, the...
This federal Project Grant award from the National Institute of General Medical Sciences (NIGMS), under the Biomedical Research and Research Training program (CFDA 93.859), provides $438,629.00 to the University of Massachusetts to investigate the fundamental mechano-molecular mechanisms of cell division. The project aims to characterize the functional contributions of large intrinsically disordered protein regions at the kinetochore and perichromosomal layer, as well as study the regulation...
This Project Grant award from the National Cancer Institute (CFDA 93.398 - Cancer Research Manpower program) provides $204,474 to The Regents of the University of Colorado to conduct research aimed at defining the relationship between cell quiescence and senescence. The project will use advanced microscopy techniques and RNA sequencing to study the molecular mechanisms that mediate the transition from a reversible quiescent state to permanent cell cycle arrest, or senescence. The research...
The National Institute of General Medical Sciences (NIGMS) awarded a $366,250 Project Grant under the Biomedical Research and Research Training program (CFDA 93.859) to Central Michigan University. The grant, which runs from January 1, 2025 to December 31, 2029, aims to develop bioluminescent kinase sensors to monitor and manipulate cell signaling processes related to cell growth, division, and the cell cycle. The proposed research seeks to create novel tools for studying cell biology and...
This Project Grant award from the National Institute of General Medical Sciences (NIGMS) Biomedical Research and Research Training program (CFDA 93.859) provides $583,698 to the University of Illinois to conduct research on the coordination of the bacterial cell cycle. The overarching goals of the 5-year project are to: (i) define the mechanisms by which the replication initiator DnaA and the partitioning system ParABS coordinate the initiation of chromosome replication with centromere...
This Project Grant award from the National Institute of General Medical Sciences (NIGMS) Biomedical Research and Research Training program (CFDA 93.859) provides $125,000.00 in funding to New York University School of Medicine to elucidate the role of the cyclin D1-CDK4/6 complex in protein homeostasis and the endoplasmic reticulum-associated degradation (ERAD) system. The key objectives of this 2-year project are to: 1) use structural techniques to understand how cyclin D-dependent...
This Project Grant award from the National Institute of General Medical Sciences (NIGMS), under the Biomedical Research and Research Training program (CFDA 93.859), provides $541,967 to the University of Chicago to investigate the mechanical behaviors of cells and their impact on physiological processes and diseases. The research aims to expand the understanding of adherent cell mechanics and mechanobiology, focusing on the force-sensitive remodeling of cell-cell adhesions and the role of LIM...
This federal Project Grant award of $387,500.00 from the National Institute of General Medical Sciences (NIGMS) Biomedical Research and Research Training program (CFDA 93.859) supports research to determine the molecular mechanisms that regulate the activity of protein kinases. The research will use the Hippo pathway, which controls decisions of cell fate and number, as a model system to investigate different mechanisms that modulate the activity of protein kinases. The goal is to accelerate the...
This Project Grant award from the National Institute of General Medical Sciences (NIGMS) Biomedical Research and Research Training program (CFDA 93.859) provides $390,000.00 to The Regents of the University of Colorado (University of Colorado-Denver) to conduct research on the molecular mechanisms of DNA replication during mitosis. The research aims to uncover how cells complete replication of the entire genome before cell division, even when replication is not fully finished in the S phase of...

This $383,891 Project Grant award from the National Institutes of Health (NIH) National Institute of General Medical Sciences (NIGMS) Biomedical Research and Research Training Program (CFDA 93.859) supports research to understand the mechanisms driving cell cycle plasticity and robustness. The principal investigator will use advanced time-lapse microscopy tools to investigate how cells can bypass inhibition of the CDK2 cell cycle regulator by activating alternative CDK4/6 pathways, enabling continued cell cycle progression. The findings aim to reveal new principles for predicting cell cycle dependencies and developing strategies to suppress adaptive cell cycle rewiring in response to targeted inhibitors. The project will be performed at the University of Colorado over a 4-year period from September 2024 to August 2028.

Generated 7/1/25, 4:11 AM